MedTrace Logo

Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy

NCT03382743 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-01-24

No results posted yet for this study

Summary

lidocaine spray is used endocervical before office hysteroscopy to reduce the pain

Conditions

  • Pain Uterus

Interventions

DRUG

Endocervical Lidocaine spray

5 sprays of endocervical Lidocaine spray (10%) is used 3 minutes before office hysteroscopy

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382743 on ClinicalTrials.gov